Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?

MLA

Lucchesi, Alessandro, et al. “Unexpected Low Expression of Platelet Fibrinogen Receptor in Patients with Chronic Myeloproliferative Neoplasms: How Does It Change with Aspirin?” British Journal of Haematology, vol. 189, no. 2, Apr. 2020, pp. 335–38. EBSCOhost, https://doi.org/10.1111/bjh.16335.

APA

Lucchesi, A., Carloni, S., De Matteis, S., Ghetti, M., Musuraca, G., Poggiaspalla, M., Augello, A. F., Giordano, G., Fattori, P. P., Martinelli, G., & Napolitano, R. (2020). Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin? British Journal of Haematology, 189(2), 335–338. https://doi.org/10.1111/bjh.16335

Chicago

Lucchesi, Alessandro, Silvia Carloni, Serena De Matteis, Martina Ghetti, Gerardo Musuraca, Monica Poggiaspalla, Accursio F. Augello, et al. 2020. “Unexpected Low Expression of Platelet Fibrinogen Receptor in Patients with Chronic Myeloproliferative Neoplasms: How Does It Change with Aspirin?” British Journal of Haematology 189 (2): 335–38. doi:10.1111/bjh.16335.